What is a normal test result? a normal reference range?

Similar documents
Preface. TTY: (888) or Hepatitis C Counseling and Testing, contact: 800-CDC-INFO ( )

Approach to Abnormal Liver Tests

Results Demographic profile of these children is shown in Table I.

Global Under Diagnosis of Viral Hepatitis

National Health Burden of CLD in Italy

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

Case Finding for Hepatitis B and Hepatitis C

Program Evaluation and the Design of Natural Experiments

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

HCSP GUIDES A GUIDE TO: PREPARING FOR TREATMENT. A publication of the Hepatitis C Support Project

New IDSA/AASLD Guidelines for Hepatitis C

Hepatitis C. Laboratory Tests and Hepatitis C

HEPATITIS COINFECTIONS

Simplifying Clinical Trial Eligibility Criteria

Alanine aminotransferase (serum, plasma)

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

PPS UNDERWRITING GUIDE FOR APPLICANTS

Patterns of abnormal LFTs and their differential diagnosis

3/25/2014. April 3, Dennison MM, et al. Ann Intern Med. 2014;160:

Health and Social Care Level 3. Unit 6 Sociological perspectives for health and social care

BEHIND UNDERSTANDING AND MANAGING. SaaS BUSINESSES. Recurly counts some of the world s most successful subscription businesses as its customers

U.S. Food and Drug Administration

Treatment of Acute Hepatitis C

Red Blood Cell Transfusions for Sickle Cell Disease

Enter this essay in the English Language Learner (for 5 years or less of English) category: _X_ Yes

Prospects for Vaccines against Hepatitis C Viruses. T. Jake Liang. M.D. Liver Diseases Branch NIDDK, NIH, HHS

Why and how to have end-of-life discussions with your patients:

Imaging Systems Laboratory II. Laboratory 4: Basic Lens Design in OSLO April 2 & 4, 2002

Research Ethics Review Committee (WHO ERC)

2.1 AST can be measured in heparin plasma or serum. 3 Summary of clinical applications and limitations of measurements

Using Liver Enzymes as Screening Tests to Predict Mortality Risk

Viral Hepatitis Case Report

LIAISON XL HCV Ab Accurate diagnosis of the early stage of HCV infection

Critical appraisal. Gary Collins. EQUATOR Network, Centre for Statistics in Medicine NDORMS, University of Oxford

MIND-BODY THERAPIES FOR HYPERTENSION

Latest advice for medicines users The monthly newsletter from the MHRA and its independent advisor the Commission on Human Medicines

Geometric Optics Converging Lenses and Mirrors Physics Lab IV

Testing the Birth Cohort for HCV at BIDMC/ CareGroup

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During

Focus on Your Future: PhD and MD-PhD Programs and Research Careers

Viral Hepatitis APHL survey report

When an occupational exposure occurs, the source patient should be evaluated for both hepatitis B and hepatitis C. (AII)

Exposure. What Healthcare Personnel Need to Know

New All Oral Therapy for Chronic Hepatitis C Virus (HCV): A Cost-Benefit Analysis

The Facts You Need To Know. Developed by

Transmission of HCV in the United States (CDC estimate)

Many people with non-hodgkin lymphoma have found an educational support group helpful. Support

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

Learning about Hepatitis C and Chronic Kidney Disease

Commonly Asked Questions About Chronic Hepatitis C

Healing Depression Naturally

Molecular Diagnosis of Hepatitis B and Hepatitis D infections

Offering Testing for Hepatitis B and C in Primary Care

Multiple Choice Questions

Assertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia

Hepatitis C Glossary of Terms

Peg-IFN and ribavirin: what sustained virologic response can be achieved by using HCV genotyping and viral kinetics?

Invitation to Tender. Department of Health Policy Research Programme

Breakthrough Lung Cancer Treatment Approved Webcast September 9, 2011 Renato Martins, M.D., M.P.H. Introduction

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NYC Health Department Surveillance Study: Barriers to Hep C Treatment Among NYC Residents

BURDEN OF LIVER DISEASE IN BRAZIL

Cirrhosis and HCV. Jonathan Israel M.D.

Supplementary Online Content

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr

Albumin. Prothrombin time. Total protein

IN THE SENATE OF THE UNITED STATES , M. introduced the following bill; which was referred to the Committee on A BILL

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

MEDICAL ASSISTANCE HANDBOOK PRIOR AUTHORIZATION OF PHARMACEUTICAL SERVICES. I. Requirements for Prior Authorization of Hepatitis C Agents

Hepatitis C Vaccines: Are we making progress?

First In Human Pediatric Trials and Safety Assessment for Rare and Orphan Diseases

Developing Innovative Therapeutics for People with Orphan Liver Disease

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Hepatitis C and pregnancy

Bataka Twetambire. let us heal ourselves

Strategies to Improve the HCV Continuum of Care:

Health Alert Communications Communication in Life Sciences

U.S. Food and Drug Administration

Abbott Diagnostics. Durable Growth Business

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

PROJECT INSPIRE NYC: COMBATTING HCV IN NYC - A CMS INNOVATION AWARD. Fabienne Laraque, MD, MPH Senior Project Director October 10th, 2014

MATH 10: Elementary Statistics and Probability Chapter 5: Continuous Random Variables

Business s Tips and Useful Phrases

) UC 6:30 8:20 PM

Hepatitis C in Colorado 2007 Surveillance Report Cases of Acute and Chronic Hepatitis C in Colorado

Appendix B: Provincial Case Definitions for Reportable Diseases

Chapter One: The Egyptian Educational System

What does Hepatitis C mean to me as a CKD Patient?

The natural history of chronic HBV infection

HEPATITIS C. The Facts. Get Tested. Get Cured! Health

GCSE BITESIZE Examinations

UCLA Asian Liver Program

Newly Diagnosed: HEPATITIS C. American Liver Foundation Support Guide

Drug Treatment - A Comprehensive Report for the UK Police

Richard M. Fairbanks School of Public Health Undergraduate Course Descriptions

In this study, the DCV+ASV regimen had low rates of discontinuation (5%) due to adverse events, and low rates of serious adverse events (5.

Risk of alcohol. Peter Anderson MD, MPH, PhD, FRCP Professor, Alcohol and Health, Maastricht University Netherlands. Zurich, 4 May 2011

Theories on Metastasis: Innovative Thinking An Advocacy Perspective

Ribavirin/Pegylated Interferon Combination Therapy for People with Hepatitis C

Transcription:

What is a normal test result? a normal reference range? John R. Senior, M.D. Office of Pharmacovigilance and Epidemiology Center for Drug Evaluation and Research Food and Drug Administration 20 March 2013 What's "normal"? 1

The word normal has many meanings: ordinary, common, usual, standard, expected, frequent, in agreement, natural, sane, desirable... some special ones that don t apply to tests: Latin: norma, a rule geometry: line or vector perpendicular to a plane or line; chemistry: N, one gram-molecular weight dissolved in a liter, or a straight-chain, aliphatic C-C-C hydrocarbon; photography: a lens of moderate focal length; education; school to train high-school graduates as teachers; mathematics: real number with uniform distribution of digits, a type of function or measure in set theory, degree of a rational curve on a surface, and many others psychiatry: of sound mind, sane 20 March 2013 What's "normal"? 2

... and some special ones that do apply: statistics: the Gaussian continuous probability distribution, the bell-shaped curve; the study of groups, low emphasis on outliers medicine: healthy, free of disease or loss of function, best possible state of being; focus on individuals, usually outliers different from most WHICH SHOULD WE USE for normal? Statistical or Medical? CAN WE AGREE? Get CONSENSUS? 20 March 2013 What's "normal"? 3

Is It Healthy to be Normal? Dufour DR. Alanine aminotransferase: Is It healthy to Be Normal? Hepatology 2009 Dec:50(6):1699-701. This was a delightful and well reasoned commentary on an article published in that issue by Dutta, Saha, Johnson, and Chalasani, who had surveyed 67 Indiana laboratories where the upper limit of the normal range varied from 31 to 72. They concluded that different machines used to measure ALTs gave quite different results. In his commentary, Bob Dufour put his finger on a more likely explanation that people used to define limits were only apparently healthy and had other reasons for increased ALT values. We shall be hearing from Bob Dufour very shortly. 20 March 2013 What's "normal"? 4

--- this is not a new question, and dates back at least 10 years --- Prati D, Taioli F, Zanella A, DellaTorre E, Butelli S, DelVecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sichia G. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002 Jul;137(1):1-9. Using data from the Milan blood bank, they found that socalled reference populations used to set normal ranges included many people with NAFLD or unrecognized chronic hepatitis C. By excluding them, they found new, lower levels for upper limit of normal as 30 for men and 19 for women, expressed as U/L, micromoles converted/minute/ml. 20 March 2013 What's "normal"? 5

Marshall Kaplan commented editorially in the same issue that consequences of this might overwhelm the health care system, make some people anxious, and decrease blood donors --- and dissented with what should be done with the findings of Prati et al. Alanine Aminotransferase Levels: What s Normal? Kaplan MM. Ann Intern Med. 2002 Jul;137(1):49-51. I applaud Prati and colleagues for their carefully done study but would not adopt their recommendations. 20 March 2013 What's "normal"? 6

--- and so did I: Healthy Ranges for Alanine Aminotransferase Levels. John R. Senior, MD. Ann Intern Med. 2003 Jan 21:138(2):156-7. TO THE EDITOR: ALT assays are widely used as a screening test for detecting liver disease in apparently healthy people, in whom the prevalence of viremic chronic HCV infection is likely to be perhaps two orders of magnitude lower, or only about 0.6% (or 6 per 1,000). Consequences of increasing sensitivity from 55% to 76% of patients with HCV antibodies was attended by a decrease in specificity from 97.1% to 88.1% and great decrease in the value of a positive test result, from 11.9% to 4.0%, which means that a positive result of the new test would be WRONG in 96%, due to the increased numbers of false-positive results. They replied that they did not propose the changes for screening, but to follow and monitor HCV-positive patients over time, and believe that ALT values are best used flexibly as a continuous, not dichotomous, variable. 20 March 2013 What's "normal"? 7

I cannot conceal my bias in favor of considering that the desired range of normal should be derived from healthy, well people, rather than a statistically common or frequent group of people that may include sick or abnormal people who may not even know it. 20 March 2013 What's "normal"? 8

Are subjects selected for controlled clinical trials all healthy, normal? Not necessarily, as we shall consider this afternoon when discussing the flood of new drugs and combinations coming to treat or possibly cure chronic hepatitis C. Many or most of them will not have normal healthy livers before starting treatment, so should they be compared to healthy, normal people or maybe not, but alternatively to themselves in how they respond to treatment. Maybe we should figure out how to do this. 20 March 2013 What's "normal"? 9

Let s think a little about how we might find a baseline in some way better than the usual assumption of a single pre-treatment point, knowing that a single point does not define a line, and we shouldn t just assume it is horizontal, indicating tht it s how it was and would be if no intervention occurred (you can insert new dates and values in the little program onthe next slide and see what happens ) 20 March 2013 What's "normal"? 10

Calculate BASELINE from screening & pretreatment values an Excel program, bslncalc.xls Take ALT as example, tests 3 weeks apart: Use both screening and pre-treatment test results. (do not start treatment until results of pre-treatment test known ) (If slope of ALT values rise at >30% per month, best not to start experimental drug or controlled study, but investigate for probab cause of rising values.) screening date: 29-Jan-13 value, U/L: 32 pre-treat date: 17-Feb-13 value, U/L: 36 slope: 0.200 PROCEED baseline: 34 average of 2 20 March 2013 What's "normal"? 11

You ll be hearing more shortly from Dr. Leonard Seeff about why it s a good Idea to calculate a baseline slope using both screening and immediate pretreatment test values rather than using the conventional upper limit of the normal range (ULN) in groups of healthy, normal people for comparisons of effects. 20 March 2013 What's "normal"? 12

But now, let s hear from Bob Dufour about what really is, or should be, considered normal, and let the debate commence 20 March 2013 What's "normal"? 13